Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

AV Therapeutics Inc


Ticker Change

Company Profile for AV Therapeutics Inc (AQOC)

AV Therapeutics, Inc. is engaged in the business of developing Cancer therapeutics and immunotherapeutic vaccines that can be used together with prevalent treatment modalities such as chemotherapy and radiation to treat active disease and to prevent metastases and recurrence.

Contact Information

AV Therapeutics Inc

20 East 68th Street, Suite 204
New York, NY 10065
United States
Fax: 917-497-5523

Key Executives for AV Therapeutics Inc (AQOC)

Abraham MittelmanChairman/CEO/CFORobert PollockPresident/COO
Raj Kumar TiwariChief Scientific OfficerMorton ColemanVice President
Jan GeliebterSecretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil